Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.
Cell culture-adaptive mutations within the hepatitis C virus (HCV) E2 glycoprotein have been widely reported. We identify here a single mutation (N415D) in E2 that arose during long-term passaging of HCV strain JFH1-infected cells. This mutation was located within E2 residues 412 to 423, a highly conserved region that is recognized by several broadly neutralizing antibodies, including the mouse monoclonal antibody (MAb) AP33. Introduction of N415D into the wild-type (WT) JFH1 genome increased the affinity of E2 to the CD81 receptor and made the virus less sensitive to neutralization by an antiserum to another essential entry factor, SR-BI. Unlike JFH1(WT), the JFH1(N415D) was not neutralized by AP33. In contrast, it was highly sensitive to neutralization by patient-derived antibodies, suggesting an increased availability of other neutralizing epitopes on the virus particle. We included in this analysis viruses carrying four other single mutations located within this conserved E2 region: T416A, N417S, and I422L were cell culture-adaptive mutations reported previously, while G418D was generated here by growing JFH1(WT) under MAb AP33 selective pressure. MAb AP33 neutralized JFH1(T416A) and JFH1(I422L) more efficiently than the WT virus, while neutralization of JFH1(N417S) and JFH1(G418D) was abrogated. The properties of all of these viruses in terms of receptor reactivity and neutralization by human antibodies were similar to JFH1(N415D), highlighting the importance of the E2 412-423 region in virus entry.
MRC Virology Unit, Institute of Virology, University of Glasgow, Glasgow, United Kingdom.
Simrat
S
Dhillon
Jeroen
J
Witteveldt
Derek
D
Gatherer
Ania M
AM
Owsianka
Mirjam B
MB
Zeisel
Muhammad N
MN
Zahid
Malgorzata
M
Rychłowska
Steven K H
SK
Foung
Thomas F
TF
Baumert
Allan G N
AG
Angus
Arvind H
AH
Patel
D057134:Antibodies, Neutralizing / Q000276:immunology*; D017124:Conserved Sequence / Q000235:genetics; D016174:Hepacivirus / Q000276:immunology*; D006801:Humans; D009154:Mutation; D011991:Receptors, Virus / Q000378:metabolism*; D014759:Viral Envelope Proteins / Q000235:genetics* / Q000502:physiology*; D053586:Virus Internalization
D057134:Antibodies, Neutralizing; D011991:Receptors, Virus; D014759:Viral Envelope Proteins; C091015:glycoprotein E2, Hepatitis C virus